[144] Guardant Health, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Guardant Health, Inc. (GH) reporting a proposed sale of 116 common shares through Charles Schwab & Co., Inc. on 08/19/2025 with an aggregate market value of $6,846.00. The shares were acquired on 08/15/2025 via a restricted stock lapse from Guardant Health and the payment/nature is listed as equity compensation. The filer or seller identified in prior transactions is Musa Tariq, who sold shares on 05/19/2025 (116 shares, $4,645.00), 06/18/2025 (3,213 shares, $158,947.00), and 07/17/2025 (116 shares, $5,591.00). The form includes the standard representation that the seller has no undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Routine insider notice showing small incremental sales and a planned sale following restricted stock vesting; limited immediate market impact.

The filing documents a proposed sale of 116 shares following a restricted stock lapse and lists three recent sales by the same person totaling 3,561 shares sold across May–July 2025. The planned sale size relative to the reported outstanding share count (124,705,857) is immaterial based on the data in the form. This is a standard compliance disclosure under Rule 144; it confirms transferability and planned market sale but provides no operating or financial performance information about the issuer.

Corporate Governance Expert

TL;DR: Form 144 reflects compliance with resale rules after equity compensation vesting; no governance red flags disclosed.

The notice records that the securities were acquired via equity compensation and that the seller affirms absence of undisclosed material information. The form includes broker details and recent sale history, which supports transparency around insider dispositions. There is no information in this filing indicating unusual timing, related-party transfers, or triggering governance events.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	116	6846.00	124705857	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/15/2025	Restricted Stock Lapse	Guardant Health, Inc.			116	08/15/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	05/19/2025	116	4645.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	06/18/2025	3213	158947.00
Musa Tariq 3100 HANOVER STREET PALO ALTO CA 94304	Guardant Health, Inc.	07/17/2025	116	5591.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Guardant Health (GH) Form 144 filed here disclose?

The Form 144 discloses a proposed sale of 116 common shares through Charles Schwab on 08/19/2025 valued at $6,846.00, acquired via a restricted stock lapse on 08/15/2025 as equity compensation.

Who is the seller named in the filing for GH?

The filing identifies prior seller activity by Musa Tariq, who sold shares on 05/19/2025 (116 shares, $4,645.00), 06/18/2025 (3,213 shares, $158,947.00), and 07/17/2025 (116 shares, $5,591.00).

How were the 116 shares being sold on 08/19/2025 acquired?

The 116 shares were acquired on 08/15/2025 through a restricted stock lapse from Guardant Health and the consideration is listed as equity compensation.

Does the Form 144 indicate any undisclosed material information about Guardant Health?

No. The signer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.

What broker is handling the proposed sale in the GH Form 144?

The broker listed for the proposed sale is Charles Schwab & Co., Inc., 3000 Schwab Way, Westlake TX 76262.